Posts Tagged: Teva Pharmaceuticals USA
Supreme Court to hear Helsinn v. Teva, decide AIA Secret Sales
On Monday, June 25, 2018, the United States Supreme Court granted cert. in Helsinn Healthcare S.A., v. Teva Pharmaceuticals USA, Inc. The single question presented by Helsinn in …
Allergan’s RESTASIS® patents declared invalid by Eastern District of Texas
Judge William C. Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals …
Obviousness-Type Double Patenting Considerations
Obviousness-type double patenting (“ODP”) is a judicially created doctrine aimed at preventing patent owners from extending patent protection beyond the statutorily afforded term. Prior to the Uruguay …
CAFC Interprets AIA On-Sale Bar: Invention details need not be public for sale to be invalidating
Earlier today the United States Court of Appeals for the Federal Circuit issued a major decision interpreting provisions of the America Invents Act (AIA), specifically the AIA …
